Nektar Therapeutics NKTR
Regular-session close
After hours · Nov 20, 4:15 PM ET
- YTD
- -28.57%
- 1 year
- -45.20%
Held by funds
85 US ETFs and mutual funds hold NKTR · largest positions
- FGCKX 0.11% of fund $112.04M
- XBI 0.37% of fund $36.37M
- VTI 0.00% of fund $33.13M
- IWM 0.04% of fund $32.69M
- FSSNX 0.08% of fund $26.94M
- VXF 0.02% of fund $15.12M
- IWO 0.08% of fund $10.56M
- FSMAX 0.03% of fund $9.59M
- VTWO 0.04% of fund $7.88M
- SCHA 0.03% of fund $6.70M
- BDSKX 0.09% of fund $5.07M
- KTD 0.51% of fund $4.55M
- FSKAX 0.00% of fund $3.93M
- VHT 0.01% of fund $3.53M
- MDSKX 0.04% of fund $2.46M
- FECGX 0.14% of fund $2.17M
- DWAS 0.52% of fund $1.93M
- LFSC 1.59% of fund $1.89M
- ITOT 0.00% of fund $1.77M
- SBIO 0.84% of fund $1.52M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.97% | 5,121,441 | 154.67M | Sep 29, 2026 |
| Two Seas Capital Lp | 9.78% | 3,345,978 | 101.05M | Sep 29, 2026 |
| Blackrock Inc. | 8.39% | 2,871,463 | 86.72M | Sep 29, 2026 |
| BVF Inc. | 6.24% | 2,134,007 | 64.45M | Sep 29, 2026 |
| State Street Corporation | 5.18% | 1,772,302 | 53.52M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.39% | 1,501,608 | 45.35M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 5.41% | 1,850,478 | 55.88M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.14% | 1,075,108 | 32.47M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.85% | 975,224 | 29.45M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.61% | 892,637 | 26.96M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 1.46% | 500,351 | 15.11M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 1.24% | 424,554 | 12.82M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs NKTR, and what each was last paid
Howard W. Robin, Chief Executive Officer, President & DirectorAverage age 61
| Name | Title | Pay | Age |
|---|---|---|---|
| Howard W. Robin | Chief Executive Officer, President & Director | $2.33M | 73 |
| Jonathan Zalevsky | Senior Vice President and Chief Research & Development Officer | $1.19M | 51 |
| Linda Rubinstein | Chief Financial Officer and Principal Financial & Accounting Officer | $461K | 59 |
| Jennifer Ruddock | Chief Business Officer | — | — |
| Mary Tagliaferri | Chief Medical Officer | — | 60 |
| Ken Franke | Senior Vice President of Biologics Process Development & Manufacturing | — | — |
| Robert Bacci | Chief People Officer and Head of Quality & Facilities | — | — |
| Spilios Asimakopoulos | Vice President of Commercial Strategy & Marketing | — | — |
| Elizabeth Zhang | VP of Legal, Corporate Counsel & Secretary | — | — |
| Jason Barnard | Chief Accounting Officer | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ROBIN HOWARD W | Chief Executive Officer | Sale | Nov 16, 2026 | 54,226 |
| WILSON MARK ANDREW | Officer | Sale | Nov 24, 2025 | 21,585 |
| ZALEVSKY JONATHAN | Officer | Sale | Nov 16, 2026 | 9,378 |
